Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
  1. 4 Open-market sale Chief Executive Officer sold 9,406 shares at $2.44 ($22,951)
  2. 4 Open-market sale Chief Data Officer sold 7,089 shares at $2.44 ($17,297)
  3. 4 Open-market sale General Counsel sold 7,084 shares at $2.44 ($17,285)
  4. 4 Open-market sale Chief Information Officer sold 6,551 shares at $2.44 ($15,984)
  5. 4 Open-market sale Chief Scientific Officer sold 5,132 shares at $2.44 ($12,522)
  6. 4 Open-market sale Chief Financial Officer sold 6,374 shares at $2.44 ($15,553)
  7. 4 Open-market sale Director sold 107 shares at $3.35 ($358)
  8. 4 Grant or award Director acquired 30,534 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale Chief Information Officer sold 3,874 shares at $4.16 ($16,116)
  11. 4 Open-market sale Chief Executive Officer sold 29,722 shares at $4.12 ($122,455)
  12. 4 Open-market sale Chief Financial Officer sold 4,818 shares at $4.12 ($19,850)
  13. 4 Open-market sale Director sold 99 shares at $4.16 ($412)
  14. 4 Open-market sale Chief Data Officer sold 1,338 shares at $4.16 ($5,566)
  15. 4 Open-market sale General Counsel sold 2,285 shares at $4.16 ($9,506)
  16. 4 Open-market sale Chief Information Officer sold 3,251 shares at $4.16 ($13,524)
  17. 4 Open-market sale Chief Scientific Officer sold 2,044 shares at $4.16 ($8,503)
  18. 4 Open-market sale Chief Financial Officer sold 540 shares at $4.16 ($2,246)
  19. 4 Planned sale Chief Information Officer sold 3,610 shares at $4.28 ($15,451)
  20. 4 Open-market sale Director sold 101 shares at $4.58 ($463)

Page 7 of 16 · 313 filings